Category Innovative Licensing and Access Pathway

MHRA to relaunch the Innovative Licensing and Access Pathway (ILAP) pathway in Q1 2025

The ILAP first launched in January 2021 to offer an integrated pre-market pathway awarding an Innovation Passport for promising medicines across England, Scotland and Wales. The pathway has seen an unprecedented number of applications and 160+ Innovation Passports have been…

Read MoreMHRA to relaunch the Innovative Licensing and Access Pathway (ILAP) pathway in Q1 2025